C07C 325/02
Thioketones
Official title: Thioketones; Oxides thereof
C07C325/02 (Thioketones) appears on 45 US grants and 43 published applications in this corpus.
Search patents in C07C- Granted patents
- 45
- Published applications
- 43
- Assignees
- 45
- Inventors
- 163
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 0 |
| 2003 | 2 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 1 | 4 |
| 2009 | 1 | 1 |
| 2010 | 2 | 1 |
| 2011 | 3 | 5 |
| 2012 | 0 | 1 |
| 2013 | 5 | 3 |
| 2014 | 2 | 4 |
| 2015 | 3 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 3 | 3 |
| 2019 | 3 | 1 |
| 2020 | 3 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 4 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Small molecule compounds having naphthylamine structure and application thereof26 Nov 2024US 12,151,999 B2Hangzhou PhecdaMed Co., Ltd.
- Oxocarbon-, pseudooxocarbon- and radialene compounds and their use24 May 2022US 11,342,504 B2Novaled GmbH
- Method of quenching singlet and triplet excited states of photodegradable pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds having electron withdrawing groups, to reduce generation of singlet oxygen28 Apr 2020US 10,632,096 B2Hallstar Beauty and Personal Care Innovations Company
- Oxocarbon-, pseudooxocarbon- and radialene compounds and their use10 Mar 2020US 10,586,926 B2Novaled GmbH
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Electrolyte solution for rechargeable lithium battery and rechargeable lithium battery including the same15 May 2025US 2025/0158129 A1Samsung SDI.Co., Ltd.
- Small molecule compounds having naphthylamine structure and application thereof3 Oct 2024US 2024/0327340 A1
- Novel anti-fibrotic drugs5 Sep 2024US 2024/0294465 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Novel compound for capping layer and organic light emitting device including same22 Aug 2024US 2024/0279158 A1Dongjin Semichem Co., Ltd.
Most cited
By later US patents
- Polymerization process with living characteristics and polymers made therefrom75US 6,642,318 B1Commonwealth Scientific and Industrial Research Organization · 2003
- Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures40US 7,345,301 B2Merck Patent GmbH · 2008
- Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound24US 8,492,544 B2Bayer Intellectual Property GmbH · 2013
- Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen23US 9,867,800 B2Hallstar Innovations Corp. · 2018
- Fibrinogen receptor antagonists20US 5,294,616 AMerck & Co., Inc. · 1994